# Aitua Ltd

> Aitua Ltd is a VC fund in Cambridge backing Health Care and Therapeutics. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Cambridge, United Kingdom
- Total investments: 1
- Last investment: Oct 2009
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.aitua.com/

Aitua Ltd is a VC fund in Cambridge focused on Health Care and Therapeutics. Aitua provides critical support to new bioventures during the first stages of the technology-to-business translation process. It works closely with entrepreneurs and scientists to create and nurture emerging companies from world-class science and technology deriving from the Babraham Research Campus and other life science clusters in the UK. Itprovides seed and early stage funding, injects specific expertise and provides access to services and facilities. This reduces cash-burn during the formative years and so enables companies to get off the ground. Aitua has a unique offering designed to accelerate the formation of quality, venture-ready early-stage companies.

## Contacts

5 contacts available for Aitua Ltd. Shizune tracks 1 team members at Aitua Ltd. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/aitua-ltd?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| John Bradshaw | Chief Financial Officer | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Crescendo Biologics | Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies. | $5.9M | Seed | Oct 12, 2009 |  |

1 of 1 investments shown.

## Co-investors
- [Avlar BioVentures](https://shizune.co/investors/profile/avlar-bioventures) — VC Fund, 1 deal together
- [UK Innovation & Science Seed Fund](https://shizune.co/investors/profile/rainbow-seed-fund) — VC Fund, 1 deal together
- [Sofinnova Partners](https://shizune.co/investors/profile/sofinnova-partners) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Aitua Ltd invest in?

Aitua Ltd invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Aitua Ltd?

Public channels for Aitua Ltd include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Aitua Ltd?

The team at Aitua Ltd includes John Bradshaw (Chief Financial Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co